Press release
Frontotemporal Dementia Market: Breakthrough Forecast Study Predicts Astounding Growth in the Upcoming Years | Alector, Autifony, Neurimmune, Oncolys, Passage Bio, CAMP4 Therapeutics, Coya Therapeutics, Denali Therapeutics, Prevail Therapeutics
DelveInsight's "Frontotemporal Dementia Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Frontotemporal Dementia Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The market report covers emerging drugs, treatment practices, market share of individual Frontotemporal Dementia therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Frontotemporal Dementia treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Frontotemporal Dementia: An Overview
FTD is a term used to describe a group of neurocognitive disorders that encompass progressive dysfunction in executive functioning, behavior, and language. There are three types of frontotemporal disorders (FTD): behavioral variant frontotemporal dementia (bvFTD), primary progressive aphasia (PPA), and movement disorders. FTD is considered young-onset dementia, occurring mainly between the ages of 45 to 65, and is the most common dementia in those under 60 years of age.
FTD occurs when brain cells in the frontal or temporal lobes die due to the build-up of abnormal proteins, leading to abnormal brain function, and more cell deaths result in brain atrophy. FTD encompasses clinical disorders that include changes in behavior, language, executive control, and often motor symptoms. In most cases, the cause of a frontotemporal disorder is unknown. In about 15-40% of people, a genetic (hereditary) cause can be identified. Individuals with a family history of frontotemporal disorders are more likely to have a congenital form of the disease than those without it.
Frontotemporal Dementia Market Key Facts
• Total Frontotemporal Dementia diagnosed prevalent cases in the 7MM was found to be 128,570 in 2021, which might increase by the end of 2032. These cases are expected to increase at a CAGR of 0.3% during the study period (2019-2032).
• Among 7MM, the United States has the highest Frontotemporal Dementia prevalent cases, with 58,960 cases in 2021.
• On the basis of type-specific diagnosed prevalent cases of Frontotemporal Dementia, bvFTD accounted for the highest number of cases in 2021 with 35,846 cases in the United States.
• Among the European countries, Germany had the highest Frontotemporal Dementia diagnosed prevalent population with 14,856 cases, followed by France with 11,983 cases in 2021. On the other hand, Spain had the lowest diagnosed prevalent population.
• Japan accounted for 11,845 diagnosed prevalent cases of Frontotemporal Dementia in the year 2021.
Discover How the Frontotemporal Dementia Market Will Grow by 2032:
https://www.delveinsight.com/report-store/frontotemporal-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Frontotemporal Dementia Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Frontotemporal Dementia therapies in the market. It also provides a detailed assessment of the Frontotemporal Dementia market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the market trend for each marketed Frontotemporal Dementia drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Frontotemporal Dementia Epidemiology
The epidemiology section covers detailed insights into the historical, and current Frontotemporal Dementia patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.
The Report Covers the Frontotemporal Dementia Epidemiology Segmented as -
• Total Diagnosed Prevalent cases of Frontotemporal Dementia (FTD) in the 7MM [2019-2032]
• Type-specific Diagnosed Prevalent cases of Frontotemporal Dementia (FTD) in the 7MM [2019-2032]
• Gene-specific Diagnosed Prevalent cases of Frontotemporal Dementia (FTD) in the 7MM [2019-2032]
Get Key Insights Into the Evolving Frontotemporal Dementia Epidemiology Trends @
https://www.delveinsight.com/report-store/frontotemporal-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Frontotemporal Dementia Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Frontotemporal Dementia market or expected to be launched during the study period. The analysis covers the market share by Frontotemporal Dementia drugs, patient uptake by therapies, and sales of each drug.
The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.
The report also covers the Frontotemporal Dementia Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Explore More About Ongoing Pipeline Development Activities @
https://www.delveinsight.com/sample-request/frontotemporal-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Frontotemporal Dementia Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Frontotemporal Dementia. Currently, Deerland Probiotics & Enzymes is leading the therapeutics market with its Frontotemporal Dementia drug candidates in the most advanced stage of clinical development.
Leading Companies in the Frontotemporal Dementia Therapeutics Market Include
• Alector Inc.
• Autifony Therapeutics
• CAMP4 Therapeutics
• Coya Therapeutics
• Denali Therapeutics Inc
• Neurimmune
• Oncolys BioPharma Inc
• Passage Bio, Inc.
• Prevail Therapeutics
• SOLA Biosciences
• Transposon Therapeutics, Inc
• Wave Life Sciences
And Many Others
Emerging and Marketed Frontotemporal Dementia Therapies Covered in the Report Include
• PR 006: Prevail Therapeutics
• Latozinemab: Alector
• PBFT-02: Passage Bio
• WVE-004: WaVe life Sciences
• EXO-050: Coya Therapeutics
And Many Others
Learn More About the Emerging Therapies & Key Companies in the Frontotemporal Dementia Therapeutics Market:
https://www.delveinsight.com/sample-request/frontotemporal-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Frontotemporal Dementia Competitive Intelligence Analysis
4. Frontotemporal Dementia Market Overview at a Glance
5. Frontotemporal Dementia Background and Overview
6. Frontotemporal Dementia Patient Journey
7. Frontotemporal Dementia Epidemiology and Patient Population
8. Frontotemporal Dementia Treatment Algorithm, Current Treatment, and Medical Practices
9. Frontotemporal Dementia Unmet Needs
10. Key Endpoints of Frontotemporal Dementia Treatment
11. Frontotemporal Dementia Marketed Products
12. Frontotemporal Dementia Emerging Therapies
13. Frontotemporal Dementia Seven Major Market Analysis
14. Attribute Analysis
15. Frontotemporal Dementia Market Outlook (7 major markets)
16. Frontotemporal Dementia Access and Reimbursement Overview
17. KOL Views on the Frontotemporal Dementia Market.
18. Frontotemporal Dementia Market Drivers
19. Frontotemporal Dementia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/frontotemporal-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Acute Ocular Pain Market
https://www.delveinsight.com/report-store/acute-ocular-pain-market
Adenoid Cystic Carcinoma Market
https://www.delveinsight.com/report-store/adenoid-cystic-carcinom-market
Frontotemporal Dementia Market
https://www.delveinsight.com/report-store/frontotemporal-dementia-market
Nephrosclerosis Market
https://www.delveinsight.com/report-store/nephrosclerosis-market
Dense Deposit Disease Market
https://www.delveinsight.com/report-store/dense-deposit-disease-market
High-Grade Glioma Market
https://www.delveinsight.com/report-store/high-grade-glioma-hgg-market
Implantable Infusion Pumps Global Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Polypoidal Choroidal Vasculopathy (PCV) Market
https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
Post-Polycythemia Vera Myelofibrosis Market
https://www.delveinsight.com/report-store/post-polycythemia-vera-myelofibrosis-market
Postmyocardial Infarction Syndrome Market
https://www.delveinsight.com/report-store/postmyocardial-infarction-syndrome-market
Acute ischemic stroke (AIS) Market
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
Candidemia Market
https://www.delveinsight.com/report-store/candidemia-market
Conductive Hearing Loss Market
https://www.delveinsight.com/report-store/conductive-hearing-loss-market
Cough in Idiopathic Pulmonary Fibrosis (IPF) Market
https://www.delveinsight.com/report-store/cough-in-idiopathic-pulmonary-fibrosis-ipf-market
Ductal Carcinoma in Situ Market
https://www.delveinsight.com/report-store/ductal-carcinoma-in-situ-market
Electroencephelographs (EEG) Pipeline Insight
https://www.delveinsight.com/report-store/electroencephelographs-eeg-pipeline-insight-and-competitive-landscape
Encephalomyelitis Market
https://www.delveinsight.com/report-store/encephalomyelitis-market
Graves Ophthalmopathy Market
https://www.delveinsight.com/report-store/graves-ophthalmopathy-market
Graves Orbitopathy Market
https://www.delveinsight.com/report-store/graves-orbitopathy-market
Hemophagocytic Lymphohistiocytosis Market
https://www.delveinsight.com/report-store/hemophagocytic-lymphohistiocytosis-market
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market
Tenosynovitis Market
https://www.delveinsight.com/report-store/tenosynovitis-market
Urticaria Or Hives Market
https://www.delveinsight.com/report-store/urticaria-or-hives-market
Dermal Regeneration Matrix Market
https://www.delveinsight.com/report-store/dermal-regeneration-matrix-market
Glioma Market
https://www.delveinsight.com/report-store/glioma-market
Angelman Syndrome Market
https://www.delveinsight.com/report-store/angelman-syndrome-market-forecast
Chronic Pancreatitis (CP) Market
https://www.delveinsight.com/report-store/chronic-pancreatitis-market
Follicular Lymphoma Market
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights
Hereditary Spastic Paraplegias Market
https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
Decompensated Cirrhosis Market
https://www.delveinsight.com/report-store/decompensated-cirrhosis-market
Hepatitis D Market
https://www.delveinsight.com/report-store/hepatitis-d-market
Nontuberculous Mycobacterial (NTM) Infections Market
https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market
Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Frontotemporal Dementia Market: Breakthrough Forecast Study Predicts Astounding Growth in the Upcoming Years | Alector, Autifony, Neurimmune, Oncolys, Passage Bio, CAMP4 Therapeutics, Coya Therapeutics, Denali Therapeutics, Prevail Therapeutics here
News-ID: 3139911 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Frontotemporal
Frontotemporal Dementia Market Set to Double by 2034, Reaching USD 4.2 Billion
The global FTD market was valued at USD 2.1 billion in 2024 and is projected to reach USD 4.2 billion by 2034, growing at a CAGR of 7.1%. Rising diagnosis rates, growing investment in neurodegenerative disease research, and expanded healthcare access are driving this growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70788
Key Market Highlights
• Increasing recognition of FTD as distinct from Alzheimer's and other dementias.
• Expanding pipeline of clinical trials…
Frontotemporal Disorders Treatment Market Projected Touch Approximately USD 7.68 …
Forecast Increase in Revenue:
Frontotemporal Disorders Treatment Market is expected to reach USD 7.68 Bn at a CAGR of 7.3% during the forecast period 2030.
Frontotemporal Disorders Treatment Market Overview:
The Frontotemporal Disorders Treatment Market focuses on the management and treatment of neurological conditions that cause damage to the brain's frontal and temporal lobes, leading to disorders such as dementia, progressive supranuclear palsy, and primary progressive aphasia. These conditions significantly impact behavior, language,…
Frontotemporal Dementia Treatment Market - Empathy in Action: Pioneering Frontot …
Newark, New Castle, USA: The "Frontotemporal Dementia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Frontotemporal Dementia Treatment Market: https://www.growthplusreports.com/report/frontotemporal-dementia-treatment-market/8569
This latest report researches the industry structure,…
Frontotemporal Dementia Treatment Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "Frontotemporal Dementia Treatment Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly studies…
Frontotemporal Disorder Treatment Market Size, Share, Impressive Industry Growth …
The global Frontotemporal Disorder treatment market is anticipated to showcase considerable growth during the forecast period (2020-2026). The rising orphan drug development initiatives by the FDA, new product launches and the growing geriatric population are some of the key factors contributing to the growth of the global Frontotemporal Disorder treatment market. According to the World Health Organization, in 2019 around 50 million people are living with dementia and the number…
Improvement In Cognitive Empathy to Drive The Frontotemporal Dementia Treatment …
The global Frontotemporal Dementia Treatment Market is bound to witness a CAGR worth satiating In Upcoming Years. In the era of cloud computing, the cloud revolution is there to break the stereotypes. Several key stakeholders are going for cloud hosting solutions providers to enhance their accounting services. This migration to cloud technology is making way for the enterprises to simplify their daily tasks, that too, conveniently and cost-effectively. As such,…
